540222:BOM
Laurus Labs Ltd
₹2,059.00
arrow_upward
+1.93%(+39.00) 1D
Oct 16, 3:59:49 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 540222...
Open
₹2,027.35
High
₹2,086.00
Low
₹2,027.35
Mkt. cap
1.11T
Avg. vol.
84.29K
Volume
103.13K
Dividend
0.10%
Quarterly dividend
₹0.50
Ex-dividend date
May 8, 2026
P/E ratio
101.80
52-wk high
₹2,086.00
52-wk low
₹870.05
EPS
₹20.23
Shares outstanding
106.44M
No. of employees
7K
Open
₹2,027.35
High
₹2,086.00
Low
₹2,027.35
Mkt. cap
1.11T
Avg. vol.
84.29K
Volume
103.13K
Dividend
0.10%
Quarterly dividend
₹0.50
Ex-dividend date
May 8, 2026
P/E ratio
101.80
52-wk high
₹2,086.00
52-wk low
₹870.05
EPS
₹20.23
Shares outstanding
106.44M
No. of employees
7K
News stories
From web sources and news partners
The Economic Times
·
16 hours ago
Laurus Labs shifts gears as CDMO emerges as key growth driver; Nuvama sees 24% upside
Kalkine India
·
2 days ago
Laurus Labs KRKA Pharma Investment: Rs 107.8 Crore Rights Issue
Profile
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
About Laurus Labs Ltd
CEOSatyanarayana Chava
Employees7.06K
Founded2005
Headquarters-
SectorPharmaceutical industry
Websitelauruslabs.com